Investing
152247 Articles
Stephens has upgraded its outlook for Neogenomics to Overweight.
Jefferies has upgraded its outlook for Acushnet to Buy.
Why large drug makers like these are worth retaining in an investment portfolio.
Why investors should thus focus on stocks like these that offer risk-adjusted returns.
Goldman Sachs maintained coverage of Applied Materials with a Buy recommendation.
Why investors should place their bets on defensive stocks like these to safeguard their portfolio returns.
Here is why the oil and gas drilling industry seems to be a good place for investors for the near-to-medium…
Here are three dividend-paying stocks retirees should consider for their nest egg portfolio.
For momentum investors, these three stocks are worth betting on now.
Investors in Ford need to pay close attention to the stock based on moves in the options market lately.
Canada, home to abundant natural resources and committed to reducing greenhouse gas emissions, is making significant strides in the EV…
Regulator penalties are just getting bigger for this subsidiary of Emera and that should have investors concerned.
Meme stock traders continue to bet big on distressed companies.
Digital asset investment products saw $55 million in outflows last week, reversing the prior week of positive flows.
Our top personal finance-related articles today. Your wallet will thank you later.